Sarah A Teter from Mountain View, CA, age 55

Resumes

Sarah Teter

view source

Sarah Teter

view source

Staff Scientist At Novozymes, Inc

view source

Location:

San Francisco Bay Area

Industry:

Biotechnology

Us Patents

Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
view source
US Patent:

8063267, Nov 22, 2011
Filed:

Mar 30, 2007
Appl. No.:

12/294573
Inventors:

Paul Harris - Carnation WA, US
Elena Vlasenko - Davis CA, US
Marcus Sakari Kauppinnen - Smørum, DK
Elizabeth Zaretsky - Reno NV, US
Sarah Teter - Menlo Park CA, US
Kimberly Brown - Elk Grove CA, US
Assignee:

Novozymes, Inc. - Davis CA
Novozymes A/S - Bagsvaerd
International Classification:

C12N 15/31
C12N 15/82
C12N 15/10
C12N 15/52
A01H 5/00
US Classification:

800288, 800284, 800295, 800278, 4353201, 435468, 536 231, 536 232, 536 237
Abstract:

The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.

Method For Stonewashing Fabrics Using Cellulase
view source
US Patent:

8198068, Jun 12, 2012
Filed:

Feb 19, 2009
Appl. No.:

12/811533
Inventors:

Guifang Wu - Beijing, CN
Sarah Teter - Menlo Park CA, US
Paul Harris - Carnation WA, US
Weijian Lai - Beijing, CN
Assignee:

Novozymes A/S - Bagsvaerd
International Classification:

D06M 16/00
C09B 67/00
C12N 9/62
US Classification:

435263, 8401, 435225
Abstract:

A method of forming localized variation of color density in the surface of a dyed cellulosic fabric with reducing back staining, with a composition comprising a cellulose having the amino acid sequence of SEQ ID NO: 2 or an amino acid sequence having at least 75% sequence identity with SEQ ID NO: 2 is provided. A method for biopolishing a cellulose-containing fabric by using the new endoglucanase is also provided.

Polypeptides Having Endoglucanase Activity And Polynucleotides Encoding Same
view source
US Patent:

8258370, Sep 4, 2012
Filed:

Oct 5, 2011
Appl. No.:

13/253586
Inventors:

Paul Harris - Carnation WA, US
Elena Vlasenko - Davis CA, US
Marcus Sakari Kauppinnen - Smorum, DK
Elizabeth Zaretsky - Reno NV, US
Sarah Teter - Menlo Park CA, US
Kimberly Brown - Elk Grove CA, US
Assignee:

Novozymes, Inc. - Davis CA
Novozymes, A/S - Bagsvaerd
International Classification:

C12N 15/31
C12N 15/82
C12N 15/10
C12N 15/52
A01H 5/00
US Classification:

800288, 800284, 800294, 800278, 4353201, 435468, 536 231, 536 232, 536 237
Abstract:

The present invention relates to isolated polypeptides having endoglucanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.

Variants Of Glycoside Hydrolases
view source
US Patent:

8383385, Feb 26, 2013
Filed:

Jan 19, 2011
Appl. No.:

13/009524
Inventors:

Sarah Teter - Mountain View CA, US
Connie Ward - Hamilton MO, US
Joel Cherry - Winters CA, US
Aubrey Jones - Davis CA, US
Paul Harris - Carnation WA, US
Jung Yi - Sacramento CA, US
Assignee:

Novozymes, Inc. - Davis CA
International Classification:

C12N 9/42
C12S 3/00
C12S 3/02
C12P 19/14
C11D 3/386
US Classification:

435209, 435267, 435274, 435 99, 510392
Abstract:

The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Variants Of Glycoside Hydrolases
view source
US Patent:

20050048619, Mar 3, 2005
Filed:

Aug 25, 2004
Appl. No.:

10/926223
Inventors:

Sarah Teter - Davis CA, US
Joel Cherry - Davis CA, US
Connie Ward - Woodland CA, US
Aubrey Jones - Davis CA, US
Paul Harris - Carnation WA, US
Jung Yi - Sacramento CA, US
Assignee:

Novozymes Biotech, Inc. - Davis CA
International Classification:

C07H021/04
C12N009/24
C12P021/04
US Classification:

435069100, 536023200, 435200000, 435320100, 435325000
Abstract:

The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Methods For Transforming And Expression Screening Of Filamentous Fungal Cells With A Dna Library
view source
US Patent:

20060172379, Aug 3, 2006
Filed:

May 26, 2005
Appl. No.:

11/140150
Inventors:

Sarah Teter - Davis CA, US
Michael Lamsa - Davis CA, US
Joel Cherry - Davis CA, US
Connie Ward - Woodland CA, US
Assignee:

Novozymes, Inc. - Davis CA
International Classification:

C12P 21/06
C12N 1/16
C12N 15/74
US Classification:

435069100, 435254300, 435484000
Abstract:

The present invention relates to methods for expression screening of filamentous fungal transformants, comprising: (a) isolating single colony transformants of a DNA library introduced into ; (b) preparing DNA from each of the single colony transformants; (c) introducing a sample of each of the DNA preparations of step (b) into separate suspensions of protoplasts of a filamentous fungus to obtain transformants thereof, wherein each transformant contains one or more copies of an individual polynucleotide from the DNA library; (d) growing the individual filamentous fungal transformants of step (c) on selective growth medium, thereby permitting growth of the filamentous fungal transformants, while suppressing growth of untransformed filamentous fungi; and (e) measuring activity or a property of each polypeptide encoded by the individual polynucleotides. The present invention also relates to isolated polynucleotides encoding polypeptides of interest obtained by such methods, to nucleic acid constructs, expression vectors, and recombinant host cells comprising the isolated polynucleotides, and to methods of producing the polypeptides encoded by the isolated polynucleotides.

Variants Of Glycoside Hydrolases
view source
US Patent:

20080167214, Jul 10, 2008
Filed:

Aug 8, 2007
Appl. No.:

11/891249
Inventors:

Sarah Teter - Davis CA, US
Joel Cherry - Davis CA, US
Connie Ward - Hamilton MT, US
Aubrey Jones - Davis CA, US
Paul Harris - Carnation WA, US
Jung Yi - Sacramento CA, US
Assignee:

Novozymes, Inc. - Davis CA
International Classification:

C11D 3/386
C12N 9/24
C07H 21/04
C12N 15/63
C12N 5/06
C12P 21/02
B09C 1/10
US Classification:

510392, 435200, 536 232, 4353201, 435325, 435 691, 435267
Abstract:

The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Compositions For Degrading Cellulosic Material
view source
US Patent:

20080299613, Dec 4, 2008
Filed:

May 30, 2008
Appl. No.:

12/130838
Inventors:

Sandra Merino - West Sacramento CA, US
Keith McFarland - Davis CA, US
Joel Cherry - Davis CA, US
Sarah Teter - Menlo Park CA, US
Assignee:

Novozymes, Inc. - Davis CA
International Classification:

C12P 21/04
C12N 1/14
C12N 9/42
C12P 1/00
US Classification:

435 691, 4352567, 435209, 435267, 435277, 435171
Abstract:

The present invention relates to cellulolytic compositions for degrading or converting cellulose-containing material and methods of producing and using the compositions.